Is BBL a laser, and how is it different?
No; BBL is a filtered intense pulsed light (IPL) system that emits many wavelengths, rather than a laser with one wavelength.
A laser produces light at one wavelength, while IPL emits a broad spectrum from which filters select certain ranges. Pigment (melanin) and red (haemoglobin) targets in the skin absorb this light and warm up. According to manufacturer information, BBL is described as a platform aiming at more controlled energy delivery than classic IPL used in many clinics; such claims should be verified independently.
HEROic is a version of the BBL family with a handpiece applied in motion. The purpose of moving application is to distribute energy more evenly across the surface. How much difference this makes varies between people, and the method cannot be said to be better than others.
Which concerns might BBL be considered for?
It can be discussed for colour-related concerns such as sun spots, superficial capillaries, diffuse redness and uneven skin tone.
Because the light targets melanin and red pigment, it may be used for superficial spots and redness. In rosacea-prone skin or diffuse redness, suitability is assessed carefully. In heat-sensitive hormonal pigmentation such as melasma, extra warmth may worsen the condition, so the choice of method needs particular care.
It is not expected to be enough alone for structural problems such as wrinkles, deep scars or marked sagging. The type and cause of a spot should be established at consultation before treatment is planned; some dark spots need dermatological assessment.
Who may not be suitable, and what are the risks?
Recent tanning, darker skin types, photosensitising medicines, pregnancy, active infection and suspicious moles or spots call for particular caution.
Applying light to tanned skin can increase the risk of burns and colour change, so sun protection before and after is important. In darker skin more light energy is absorbed, which increases the risk of pigment change. Isotretinoin use, photosensitising medicines, pregnancy and an active infection or cold sore in the area can delay treatment. A suspicious mole or spot needs dermatological examination first.
Redness, mild swelling and temporary darkening of spots can be expected afterwards. Crusting, burns, temporary colour change or scarring have been reported rarely. If a problem persists, contact your doctor.
How many sessions are needed and how is progress followed?
The number of sessions varies with the goal and skin; several sessions a few weeks apart are commonly planned and reassessed according to response.
After the first session, spots may darken and flake or fade over a few days. Redness and vessels respond more slowly. Because of lifelong sun exposure new spots can form, so ongoing sun protection is part of the plan.
Response is individual, so no exact result or duration is promised. If the skin responds differently from expected in a session, the plan may be changed.
Frequently asked questions
What is the main difference between BBL and a laser?
A laser uses one wavelength, while BBL emits filtered broad-spectrum light. Each is suitable in some situations and not in others.
Can I go into the sun after BBL?
Sun protection after the procedure is important. For duration and protection advice, follow the doctor's guidance.
Can people with darker skin have BBL?
The risk of colour change may be higher in darker skin, so suitability is assessed carefully and other methods are sometimes preferred.
Is BBL good for melasma?
Melasma is heat-sensitive and may worsen with light treatment. The approach is set by the doctor after dermatological assessment.
Sources (4)
- U.S. FDA (510(k) Premarket Notification database): 510(k) K032460: PROFILE BBL SYSTEM (2003)
- U.S. FDA (510(k) Premarket Notification database): 510(k) K101916: JOULE MULTI-PLATFORM SYSTEM (2011)
- Dermatologic Surgery: Intense pulsed light as a nonablative approach to photoaging (2005)
- European Commission: Commission Implementing Regulation (EU) 2022/2346 laying down common specifications for the groups of products without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745 (2022)
This content is for general information and does not replace a personal medical assessment.